Secondary analysis of the phase 3 EoE KIDS trial validating a caregiver questionnaire (PESQ-C) in 99 children aged 1-11 with eosinophilic oesophagitis: test-retest reliability was high (ICC 0.94) and construct validity moderate; meaningful change could not be quantified.
Secondary analysisn = 99
Chehade et al. Validation of the Novel Pediatric Eosinophilic Esophagitis Sign/Symptom Questionnaire-Caregiver Version in EoE KIDS